Chemotherapy-related hemolytic-uremic syndrome after the treatment of head and neck cancer. A case report
Open Access
- 1 November 1990
- Vol. 66 (9) , 1914-1918
- https://doi.org/10.1002/1097-0142(19901101)66:9<1914::aid-cncr2820660910>3.0.co;2-g
Abstract
A 62‐year‐old woman who was being treated for squamous cell carcinoma of the head and neck developed a chemotherapy‐related hemolytic‐uremic syndrome during the second cycle of neoadjuvant chemotherapy consisting of cisplatin, bleomycin, and methotrexate. Though the syndrome was suspected early, attempts at reversing the hematologic and renal abnormalities were unsuccessful. At postmortem examination, the characteristic microvascular lesions of the hemolyticuremic syndrome were found in the kidneys.This publication has 18 references indexed in Scilit:
- A syndrome of microangiopathic hemolytic anemia, renal impairment, and pulmonary edema in chemotherapy-treated patients with adenocarcinomaCancer, 1986
- Thrombotic thrombocytopenic purpura subsequent to acute myelogenous leukemia chemotherapyAmerican Journal of Hematology, 1986
- Treatment of cancer-associated hemolytic uremic syndrome with staphylococcal protein A immunoperfusion.Journal of Clinical Oncology, 1986
- Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy.Journal of Clinical Oncology, 1985
- Elevated Plasma von Willebrand Factor Levels and Arterial Occlusive Complications Associated with Cisplatin-Based ChemotherapyOncology, 1985
- Renal complications of mitomycin C therapy with special reference to the total doseCancer, 1985
- Renal failure and hemolytic anemia associated with mitomycin C. A case reportCancer, 1985
- Renal vascular lesions after chemotherapy with vinblastine, bleomycin, and cisplatinThe American Journal of Medicine, 1982
- Chronic glomerular microangiopathy and metastatic carcinomaHuman Pathology, 1979
- Treatment of advanced gastrointestinal cancer with 5-fluorouracil and mitomycin CCancer, 1979